Skip Ribbon Commands
Skip to main content

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Emerging Indications for TAVR

November 21, 2017 - This webcast discusses the expanding indications for use of TAVR in additional patient populations. Faculty: Drs. Michael J. Mack, Jeffrey Popma, Steven Yakubov, Vinod Thourani. Watch the webcast on TAVR »


​The Largest Transcatheter Aortic Valve Replacement Program in Metroplex Celebrates Achievement

November 20, 2017 - On Nov. 15, Baylor Scott & White The Heart Hospital – Plano completed its 1,000th transcatheter aortic valve replacement (TAVR) procedure. Baylor Scott & White Heart – Plano was a pioneer in the development of TAVR. Read the article on the 1,000th TAVR procedure »


HeartFlowCorindus Incorporating HeartFlow Technology with CorPath GRX System

October 23, 2017 - Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, announced today that it will incorporate the HeartFlow® FFRct Analysis in a case series of robotic-assisted percutaneous coronary intervention (PCI) procedures with the CorPath® GRX System to evaluate the feasibility and utility of clinical decision support. Read the full article on the HeartFlow FFRct Analysis »


CorPath GRX System​​Corindus PRECISION GRX Registry

September 12, 2017 - Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, today announced first patient enrollment in the PRECISION GRX Registry, a post-market study to continue market surveillance of the Company's second generation CorPath® GRX System. Read the full article on the GRX Registry »


Dr. J. Brian DeVille50th WATCHMAN Procedure Performed at Baylor Scott & White Heart – Plano

August 8, 2017 - Baylor Scott & White Heart – Plano performed their 50th WATCHMAN™ procedure on Tuesday, August 8, 2017. Earlier this year, Baylor Scott & White Heart – Plano was among the first hospitals in Dallas-Fort Worth to offer the WATCHMAN procedure as an alternative to long-term warfarin medication. This achievement represents significant growth of the Left Atrial Appendage Management Program. Read the WATCHMAN article »


1000 Robotic Surgeries1,000 Robotic Surgeries – A Grand Achievement by Texas' Leader in Cardiothoracic Robotics

March 31, 2017 - As the largest cardiothoracic robotic surgery program in Texas, Baylor Scott & White Heart – Plano has achieved what few hospitals worldwide have: 1,000 cardiothoracic procedures using minimally invasive robotic surgery.* This type of minimally invasive surgery allows for shorter hospital stays and fewer complications compared to the national average for traditional surgery.** That's the kind of surgical experience you can feel good about. Read the full article on robotic surgeries »

*Based on volume data provided by Intuitive Surgical. **Based on Press Ganey® database scores for period 2007 through 2016.


Photo of the Corindus CorPath SystemBaylor Scott & White Heart – Plano Performs First Robotic-Assisted Peripheral Intervention in Texas

Patients with peripheral artery disease can now be treated with new technology

March 24, 2017 - Baylor Scott & White Heart – Plano announces the successful completion of the first robotic-assisted peripheral intervention in Texas on Feb. 13. The procedure has been performed using Corindus Vascular Robotics CorPath System—the first and only Food and Drug Administration-cleared medical device used for robotic-assisted peripheral vascular interventions. These procedures involve placing stents in small arteries in intestines or legs to improve blood flow. Read the full article on robotic-assisted peripheral intervention »


GORE TAG

Baylor Scott & White Heart – Plano only approved implant site for the Pivotal Study of GORE® TAG® Thoracic Branch Endoprosthesis in North Texas​

​Enrollment begins on new clinical study for the first device designed specifically for the endovascular treatment of aortic arch and descending thoracic aorta lesions, while maintaining flow into a single aortic arch branch vessel.

March 3, 2017 - Baylor Scott & White Heart – Plano is proud to be the only approved implant site in North Texas for the W.L. Gore & Associates, Inc. (Gore) GORE® TAG® Thoracic Branch Endoprosthesis (TBE) privotal study. William Brinkman, MD, medical director, Thoracic Aortic Disease Center, Baylor Scott & White Heart – Plano is the principal investigator for the pivotal trial at this site. Read the full article on the GORE TAG »

Image courtesy of W.L. Gore & Associates, Inc.


Photo of the WATCHMAN ImplantBaylor Scott & White Heart – Plano Becomes Official Implant Center for WATCHMAN™ Device​ ​

Baylor Scott & White Heart – Plano is among the first hospitals in Dallas-Fort Worth to offer patients with non-valvular atrial fibrillation (AF) an alternative to long-term warfarin medication with the newly approved WATCHMAN Left Atrial Appendage Closure (LAAC) Implant

February 16, 2017 - ​For patients with AF who are considered suitable for warfarin by their physicians but who have reason to seek a non-drug alternative, the WATCHMAN LAAC Implant is an implant alternative to reduce their risk of AF-related stroke​. The WATCHMAN​ Implant closes off an area of the heart called the left atrial appendage (LAA) to keep harmful blood clots from the LAA from entering the blood stream and potentially causing a stroke. By closing off the LAA, the risk of stroke may be reduced and, over time, patients may be able to stop taking warfarin. Read the full article on the WATCHMAN »


Baylor Scott & White The Heart Hospital – Plano logoBaylor Scott & White Heart – Plano Honored for Commitment to Improving Vascular Care

February 15, 2017 - Baylor Scott & White Heart – Plano is one of only 42 of 317 eligible health care facilities in the United States to receive 3 Stars — the highest score possible — during the Society of Vascular Surgery's 2016 Vascular Quality Initiative (VQI) Participation Awards. It is the second consecutive year Baylor Scott & White Heart – Plano has received the 3 Star honor, which recognizes the importance of tracking and reporting outcomes of patients who have had vascular procedures. Read the full article on vascular care »


Illustration of the St. Jude Medical EnSite Precision​Baylor Scott & White Heart – Plano is First in North Texas to Utilize Next Generation Cardiac Mapping System

New technology gives detailed look inside the heart for treatment of irregular heartbeat

February 10, 2017 - Baylor Scott & White Heart – Plano is the first North Texas hospital to use the St. Jude Medical™ EnSite Precision™ cardiac mapping system, a next generation technology that helps physicians diagnose arrhythmias, or irregular heartbeats, and determine the best treatment options. Read the full article on the cardiac mapping system ​»

Image courtesy of: St. Jude Medical™ EnSite Precision™


CorPath SystemBaylor Scott & White Heart – Plano Performs First Robotic-Assisted Angioplasty in DFW

​Patients with coronary artery disease can now be treated with new robotic-assisted technology

January 19, 2017 – Baylor Scott & White Heart – Plano​ today announced the successful completion of the first robotic-assisted coronary angioplasty in the Dallas-Fort Worth region. The procedure has been performed using Corindus Vascular Robotics CorPath System​—the first and only FDA-cleared medical device to bring robotic-assisted precision to coronary angioplasty procedures. Read the full article on robotic-assisted angioplasty »​​

Cardiovascular IQ NEWSLETTER SUBSCRIPTION

Email Address: *
​​

CARDIOVASCULAR IQ


​​